Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2026-01-02 @ 3:31 AM
Study NCT ID:
NCT05103332
Status:
COMPLETED
Last Update Posted:
2025-11-03
First Post:
2021-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)
Sponsor:
Alnylam Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-22
First Submit QC Date:
None
Study First Post Date:
2021-11-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-05-09
Results First Submit QC Date:
None
Results First Post Date:
2025-07-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-07-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-17
Last Update Post Date:
2025-11-03
Last Update Post Date Type:
ESTIMATED